Study of L2-01 for people newly diagnosed with Crohn's disease
Part of Digestive system, Immune system & allergy clinical trials.
This study tests an experimental treatment called L2-01 for people recently diagnosed with Crohn's disease. The goal is to see if it's safe and helps control the disease, compared to a placebo (a dummy treatment).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have been diagnosed with Crohn's disease within the last year.
- Your Crohn's symptoms should be relatively quiet (not a severe flare) right now.
- You must not have taken certain immune-suppressing drugs recently (like infliximab within 8 weeks, or tacrolimus within 4 weeks).
- You must be free of serious infections and not have major uncontrolled health problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental cell therapy called ATORM-C for people with Crohn's disease who haven't gotten better with standard treatments. The goal is to see if this new treatment can help heal the intestinal ulcers that cause symptoms.
This study tests a new oral treatment called EXL01 to see if it can prevent Crohn's disease from coming back after surgery to remove part of the small and large intestine. It may be an option if you are not planning to use strong immune-suppressing drugs (except anti-TNF) in the next 6 months.
This trial tests whether a type of stem cell called HB-adMSCs can help treat Crohn's disease. It is for adults with mild to moderate Crohn's who have certain signs of inflammation in their blood and recent imaging of their condition.
This study tests injections of stem cells placed directly into Crohn’s affected tissue. It may help people whose Crohn’s disease lesions have not responded to standard medicines and biologic therapies.
This early-phase study tests whether a stem cell transplant can improve Crohn’s disease in teens and young adults whose disease is active and not responding to standard medicines. It may help some people who are not doing well despite several prior treatments, but it also involves intensive study procedures and safety checks.
This Phase 2 study tests whether a transplant using your own stem cells can calm active Crohn’s disease that hasn’t improved with standard medicines. It may help some people with ongoing inflammation and symptoms after multiple Crohn’s treatments.
Hear when a new Crohn&Amp;#39;s trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.